Clario Expands Neuroscience Expertise with Acquisition of NeuroRx Imaging Provider Clario has successfully acquired NeuroRx, enhancing its capabilities in neuroscience and medical imaging. This strategic move will support drug development.

Clario Expands Neuroscience Expertise with Acquisition of NeuroRx Imaging Provider #USA #Philadelphia #Clario #NeuroRx #Imaging

Clario Enhances Neuroscience Expertise with Acquisition of NeuroRx Imaging Provider In a significant strategic move, Clario has acquired NeuroRx, expanding its capabilities in neuroscience and imaging. This acquisition will empower medical innovation in clinical trials.

Clario Enhances Neuroscience Expertise with Acquisition of NeuroRx Imaging Provider #USA #Philadelphia #Clario #NeuroRx #Imaging

A high-fidelity CRISPR-Cas13 system improves abnormalities associated with C9ORF72-linked ALS/FTD - Nature Communications An expansion of a hexanucleotide repeat in the C9ORF72 gene can cause ALS. Here, the authors develop a high-fidelity RNA-targeting CRISPR system to suppress the repeat RNA expressed from the C9ORF72…

CRISPR-Cas13 variant targets C9ORF72 G4C2 repeat expansion, improving ALS/FTD symptoms. Enhanced precision & reduced collateral in gene editing. #NeuroRx PMID:39779681, Nat Commun 2025, @NatureComms

Hope And Hype For New Type Of Antidepressant Two brothers – one an entrepreneur, the other a Columbia ...

Hope And Hype For New Type Of #Antidepressant http://onforb.es/1BLZrjH via @forbes #NeuroRX #mentalhealth